ATHA Competitors & Alternatives
Compare Athira Pharma Inc with similar stocks in the same industry
Biotechnology
ATHA
Main Stock$6.75
Tradestie Score
38
Market Cap
$16.56M
Analyst Upside
-40.7%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.66
|
$202.58M | - | 60 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 65 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.31
|
$154.27M | - | 62 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.42
|
$153.02M | - | 45 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.79
|
$133.50M | - | 51 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.78
|
$114.01M | - | 53 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.13
|
$110.20M | - | 64 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$3.98
|
$85.47M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.03
|
$67.94M | - | 57 | Compare |
More ATHA Analysis
Data updated: Oct 28, 2026 | Industry: Biotechnology (SIC 2836)
217 stocks in this industry